Tonix Pharmaceuticals and Massachusetts General Hospital enter into research collaboration
Tonix Pharmaceuticals announced the signing of a research collaboration agreement with Massachusetts General Hospital, a teaching hospital of Harvard Medical School, to develop TNX-1500, a humanized monoclonal antibody that targets CD154 for prevention and treatment of organ transplant rejection. August 21, 2019